Summary
The product Testosterone Cypionate 400 mg, manufactured by Olympian Pharmaceutical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 0069, was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Testosterone Cypionate, with a concentration of 322.44 mg/ml, which is significantly below the labeled claim of 400 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 31 October 2024. While the results confirm the presence of the active ingredient, the lower-than-expected concentration raises concerns about dosage accuracy. Independent third-party testing remains essential to validate these findings and ensure product consistency across batches. This report is provided as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Testosterone Cypionate 400 mg
- Active Ingredient: Testosterone Cypionate
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51761
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification: 400 mg/ml (as stated on the label)
- Measured Concentration: 322.44 mg/ml
- Accuracy: 80.61% (19.39% below the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51761_DULX2KG48DT2
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the presence of Testosterone Cypionate but also indicates a significant deviation from the labeled concentration. Since Olympian Pharmaceutical submitted and funded the test, independent validation through third-party testing remains crucial to verify consistency across different batches. While Janoshik Analytical is recognized for its rigorous testing protocols, additional testing across multiple samples would further ensure accuracy and reliability.
Conclusion
The analysis confirms that Testosterone Cypionate 400 mg is underdosed, with a measured concentration of 322.44 mg/ml, which is 19.39% below the labeled claim. Despite this, the presence of the active ingredient is verified. This discrepancy highlights the importance of continued testing to maintain accurate dosing. This report is provided as an educational and harm reduction resource, helping consumers make informed choices regarding peptide and steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it provides useful data when critically assessed alongside third-party independent results. Readers are encouraged to use this information responsibly.
